Efficacy and safety of erenumab in women with a history of menstrual migraine

BACKGROUND: We performed a post hoc, subgroup analysis of a phase 3, randomized, double-blind, placebo-controlled study of erenumab for prevention of episodic migraine (STRIVE) to determine the efficacy and safety of erenumab in women with self-reported menstrual migraine. METHODS: Patients received...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavlovic, Jelena M., Paemeleire, Koen, Göbel, Hartmut, Bonner, Jo, Rapoport, Alan, Kagan, Risa, Zhang, Feng, Picard, Hernan, Mikol, Daniel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398400/
https://www.ncbi.nlm.nih.gov/pubmed/32746775
http://dx.doi.org/10.1186/s10194-020-01167-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398400/
https://www.ncbi.nlm.nih.gov/pubmed/32746775
http://dx.doi.org/10.1186/s10194-020-01167-6

Ejemplares similares